Quidel Corporation
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Quidel Corporation sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Quidel Corporation: 9 sponsored US clinical trials, none currently recruiting.
Quidel Corporation sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. The most-studied condition in this pipeline is Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans), with 1 trials.
Top-decile sponsor footprint
Quidel Corporation ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
Sofia 2 Lyme FIA Whole Blood Clinical Study
NCT03238274
QuickVue Influenza A + B Test Field Study
NCT03417869
"Solana™ Trichomonas Assay Field Study"
NCT02566447
Strep A FIA Field Study, Sofia
NCT02153008
Sofia hCG FIA Field Study
NCT01803113
Sofia RSV FIA Field Study
NCT01734668
Sofia Strep A FIA Field Study
NCT01494792
Strep A Fluorescent Immunoassay and Analyzer Field Study
NCT01441479
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
NCT01309568
How the Quidel Corporation archive is shaped
9 indexed studies, none listed as recruiting (0% open); 8 completed (89%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans) (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Quidel Corporation: archived-pipeline peers nationwide
Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Quidel Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 archived trials
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Quidel Corporation page
9 registered trials is a research-attention snapshot, not an endorsement of Quidel Corporation or any single study.
- None of Quidel Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans) is the condition Quidel Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Quidel Corporation pipeline card: 9 registered trials from official public datasets.Report a data error.